Palisade Bio, Inc.

PALI

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001357459

SEC filings (opens in a new tab)

In the last 90 days, Palisade Bio, Inc. insiders filed 3 open-market purchases and 2 sales; 124 institutions reported holding it in 13F filings for Q2 2026, worth $362.4M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Palisade Bio, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of PALI: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	11	13	+2
Shares	134.6K	149.9K	+15.4K (+11.4%)
Value	$228.7K	$86.6K	−$142.1K (−62.1%)

New holders (3)

Institutions that held Palisade Bio, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to PALI in Q3 2023
Institution	Shares	Value	% of portfolio
Warberg Asset Management LLC	10,000	$5.82K	0.00%
Baader Bank INC	10,423	$5.41K	0.00%
Orion Capital Management LLC	299	$174	0.00%

Sold out (1)

Institutions that held Palisade Bio, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of PALI in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Bank of America Corp	30,000	$51.0K